跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 101,473 条关于
“High-grade B-Cell Lymphoma”
全部
101,473
临床试验
67,597
药物
6,732
机构
3,431
资讯
23,713
去年
ViPOR Regimen Shows Durable Remissions in Relapsed DLBCL Subtypes
去年
Epcoritamab Demonstrates Durable 3-Year Remissions in Relapsed/Refractory Large B-Cell Lymphoma
2年前
Roche's Glofitamab Expands Treatment Horizons for Multiple B-Cell Lymphomas
去年
Glofitamab Plus Polatuzumab Demonstrates Durable Responses in Relapsed/Refractory LBCL
去年
Genentech Presents Encouraging Long-Term Data for Lymphoma and Hemophilia Treatments
去年
Yescarta Approved in Scotland as First Second-Line CAR-T Therapy for DLBCL
9个月前
Arvinas Reports Promising Preclinical Data for ARV-393 and Glofitamab Combination in B-Cell Lymphoma
去年
Epcoritamab Approved by FDA for Relapsed/Refractory Follicular Lymphoma
去年
CAR-T Therapies AT-19 and XYF-19 Show Promise in Treating B-Cell Lymphomas
6个月前
Chugai Receives World-First Approval for Lunsumio-Polivy Combination in Relapsed Large B-Cell Lymphoma
第 1 页，共 2372 页
上一页
下一页
